MedPath

Evaluation of the efficacy of clonazepam oral paste on pain of burning mouth syndrome

Phase 2
Conditions
Burning mouth syndrome.
Burn of mouth and pharynx, sequela
T28.0XXS
Registration Number
IRCT20120101008585N13
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
24
Inclusion Criteria

The patients with primary BMS whose disease have been confirmed by a specialist

Exclusion Criteria

The patients with primary BMS who have been under treatment for BMS during previous month
The patients who have taken anxiolytics, antidepressant or any other similar medications

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The amount of pain. Timepoint: Day 0,7,14,21,30. Method of measurement: Visual anloge scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath